Rho kinase in patients with atherosclerosis: effects of statins- a double blind, randomized clinical trial comparing rosuvastatin and atorvastatin

Trial Profile

Rho kinase in patients with atherosclerosis: effects of statins- a double blind, randomized clinical trial comparing rosuvastatin and atorvastatin

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Apr 2007

At a glance

  • Drugs Atorvastatin (Primary) ; Rosuvastatin (Primary)
  • Indications Atherosclerosis; Myocardial infarction; Peripheral arterial disorders; Stroke
  • Focus Pharmacodynamics
  • Most Recent Events

    • 18 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top